Evidence map›Paper›PMID 40622944›Full record

ArticlePloS one2025

Association between shortened maternal and fetal telomere length and abnormal fetal development.

Océane Coudrieu, Zangbéwendé Guy Ouedraogo, Denis Gallot, Amélie Delabaere, Lauren Veronese, Eleonore Eymard-Pierre, Andrei Tchirkov, Carole Goumy

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Océane CoudrieuCytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France.
Zangbéwendé Guy OuedraogoCytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France.
Denis GallotUnité de Médecine Fœtale, CHU Clermont-Ferrand, CHU Estaing, Clermont-Ferrand, France.
Amélie DelabaereUnité de Médecine Fœtale, CHU Clermont-Ferrand, CHU Estaing, Clermont-Ferrand, France.
Lauren VeroneseCytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France.
Eleonore Eymard-PierreCytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France.
Andrei TchirkovCytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France.
Carole GoumyCytogénétique Médicale, CHU Estaing; Université Clermont Auvergne, UFR de Médecine et professions paramédicales, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-6302-9383

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of intrinsic, maternal and environmental factors have been linked to the risk of fetal developmental anomalies. In a previous study, we showed that telomere length (TL) was notably reduced in amniotic fluid when the fetus exhibited a developmental anomaly. In this new study, we measured the fetal and maternal TL for 75 evolutive pregnancies with congenital malformation. We also measured the TL of 50 pregnant women without fetal anomalies and 50 non-pregnant control women who had at least one child with normal development. In fetal samples, telomeres were significantly shortened in cases with congenital anomalies compared to controls (n  =  93) (P  <  0.0001). Interestingly, age-adjusted maternal TL was also significantly reduced in these cases (P  <  0.01). Receiver operating characteristic (ROC) analysis showed that maternal TL, at the optimal cut-off value, identified cases of congenital anomalies with 92% specificity and 73% sensitivity. In addition, fetal and maternal TL were correlated, with 15% to 38% of the variance in fetal TL attributable to maternal TL. Telomere shortening can lead to increased sensitivity to various maternal exposure factors and may contribute to compromised organogenesis, possibly due to inadequate cell proliferation or genomic instability. Measuring maternal TL during the periconceptional period could serve as a useful predictive biomarker for assessing the risk of fetal developmental anomalies.

Indexed as

Congenital AbnormalitiesFetal DevelopmentFetusTelomereTelomere ShorteningAdultCase-Control StudiesFemaleHumansPregnancyROC Curve

Identifiers

PMID40622944
PMCPMC12233292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.